NEW YORK, NY / ACCESSWIRE / July 26, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Zuora, Inc. (NYSE: ZUO)

Investors Affected : April 12, 2018 – May 30, 2019

A class action has commenced on behalf of certain shareholders in Zuora, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company would focus on implementing RevPro for new customers ahead of the deadline to comply with accounting standard ASC 606; (2) as a result, the Company lacked adequate resources to integrate RevPro with the core business; (3) the Company would focus on RevPro integration a year after the acquisition closed; (4) delays in integrating RevPro would materially impact the business; (5) the market for RevPro was limited to customers seeking to implement new accounting standards such as ASC 606; (6) after the deadline for ASC 606 compliance passed, demand for RevPro was reasonably likely to decline; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/zuora-inc-loss-submission-form/?id=2633&from=1

FedEx Corporation (NYSE: FDX)

Investors Affected : September 19, 2017 – December 18, 2018

A class action has commenced on behalf of certain shareholders in FedEx Corporation. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) TNT’s overall package volume growth was slowing as TNT’s large customers permanently took their business to competitors after the Cyberattack; (2) as a result of the customer attrition, TNT was experiencing an increased shift in product mix from higher-margin parcel services to lower-margin freight services; (3) the anticipated costs and timeframe to integrate and restore the TNT network were significantly larger and longer than disclosed; (4) FedEx was not on track to achieve TNT synergy targets; and (5) as a result of these undisclosed negative trends and cost issues, FedEx’s positive statements about TNT’s recovery from the Cyberattack, integration into FedEx’s legacy operations, customer mix, customer service levels, profitability, and prospects lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/fedex-corporation-loss-submission-form/?id=2633&from=1

Eagle Bancorp, Inc. (NASDAQCM: EGBN)

Investors Affected : March 2, 2015 – July 17, 2019

A class action has commenced on behalf of certain shareholders in Eagle Bancorp, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Eagle Bancorp’s internal controls and procedures and compliance policies were inadequate; (ii) the foregoing shortcoming created a foreseeable risk of heightened regulatory scrutiny and the need for the Company undertake its own internal investigations; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/eagle-bancorp-inc-loss-submission-form/?id=2633&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 553628

NEW YORK, NY / ACCESSWIRE / July 26, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Mammoth Energy Services, Inc. (“Mammoth” or the “Company”) (NASDAQ: TUSK) of the August 6, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Mammoth stock or options between October 19, 2017 and June 5, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/TUSK. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Western District of Oklahoma on behalf of all those who purchased Mammoth securities between October 19, 2017 and June 5, 2019 (the “Class Period”). The case, Scuderi v. Mammoth Energy Services Inc. No. 5:19-cv-00522 was filed on June 7, 2019 and has been assigned to Judge Scott L. Palk.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Mammoth’s subsidiary, Cobra, improperly obtained two infrastructure contracts with PREPA that totaled over $1.8 billion; (2) specifically, the contracts were awarded as the result of improper steering and not a competitive RFP process; and (3) as a result, Defendants’ statements about Mammoth’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Specifically, on May 24, 2019, the Wall Street Journal published an article entitled “FEMA Official Probed Over Puerto Rico Power Restoration” stating that the Federal Emergency Management Agency (“FEMA”) Deputy Regional Administrator, who oversaw FEMA’s response to the damage brought by Hurricane Maria, was under investigation by the Department of Homeland Security (“DHS”), was relieved of her duties and placed on administrative leave over allegations that she steered work to Cobra.

On this news, the Company’s stock price fell-over three trading days-from $12.24 per share on May 23, 2019 to $10.99 per share on May 29, 2019: a $1.25 or 10.21% drop.

Then, on June 5, 2019, the Wall Street Journal published an article titled, “Puerto Rico Grid Contractor Caught Up in Federal Probes”. According to the article, the Department of Homeland Security’s Inspector General is investigating one of Mammoth Energy’s subsidiaries in Puerto Rico to determine how the company came to dominate the power restoration efforts there since 2017. The Federal Bureau of Investigation opened a related criminal investigation.

On this news, the Company’ stock price fell-over two trading days-from $11.20 per share on June 5, 2019 to $6.11 per share on June 6, 2019: a $5.09 or 45.45% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Mammoth’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 553527

NEW YORK, NY / ACCESSWIRE / July 29, 2019 / Vapotherm, Inc. (NYSE: VAPO) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 29, 2019 at 4:30 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/C-FD2C94CD8FE76

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 553632

NEW YORK, NY / ACCESSWIRE / July 26, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Metro Bank PLC (OTCMKTS: MBNKF)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/metro-bank-plc-loss-submission-form?prid=2632&wire=1
Lead Plaintiff Deadline: July 29, 2019
Class Period: March 6, 2018 to May 1, 2019

Allegations against MBNKF include that: (1) Metro Bank misclassified the risk terms of many of its loans; (2) accordingly, Metro Bank failed to maintain sufficient capital; (3) this conduct would lead to investigations by the PRA and FCA; (4) this conduct would also lead to the reduction of deposits at Metro Bank from larger commercial and partnership clients; and (5) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

A. O. Smith Corporation (NYSE: AOS)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/a-o-smith-corporation-loss-submission-form?prid=2632&wire=1
Lead Plaintiff Deadline: July 29, 2019
Class Period: July 26, 2016 to May 16, 2019

Allegations against AOS include that: (a) A.O. Smith had undisclosed business connections and entanglements with UTP through which it funneled up to 75% of its China product sales; (b) A.O. Smith had used UTP to engage in channel stuffing by artificially inflating inventories purportedly sold through distributors that were not based on consumer demand, thereby approximately doubling the normal level of inventory at such distributors; (c) A.O. Smith had used its UTP relationship to artificially inflate the sales figures it reported to investors by as much as 8% and to conceal worsening sales trends that the Company was experiencing in China; (d) A.O. Smith’s sales growth had been primarily in lower margin products as its higher priced products were being undercut by competition in “second-tier” Chinese cities, causing the Company to experience significant margin pressures; (e) A.O. Smith had increased its cash reserves in China to over $530 million in furtherance of its channel stuffing and sales manipulation scheme, encumbering the Company’s ability to repatriate the cash or use it for capital expenditures; and (f) as a result of (a)-(e) above, A.O. Smith’s business, operations, and prospects were significantly worse than publicly represented and the Company was poised for sales and earnings declines in China, its most important international market.

Box, Inc. (NYSE: BOX)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/box-inc-loss-submission-form?prid=2632&wire=1
Lead Plaintiff Deadline: August 5, 2019
Class Period: November 28, 2018 to June 3, 2019

Allegations against BOX include that: (1) the Company was unable to close large deals within the quarter; (2) that, as a result, the Company’s revenue would be materially impacted; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 553627

NEW YORK, NY / ACCESSWIRE / July 26, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Community Health Systems, Inc. (NYSE: CYH)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/community-health-systems-inc-loss-submission-form?prid=2631&wire=1
Lead Plaintiff Deadline: July 29, 2019
Class Period: February 20, 2017 to February 27, 2018

Allegations against CYH include that: (1) the Company had understated its contractual allowances; (2) the Company had understated its provision for bad debts; (3) as a result, the Company had overstated its net operating revenue; (4) as a result, the Company had understated its net loss; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Realogy Holdings Corp. (NYSE: RLGY)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/realogy-holdings-corp-loss-submission-form?prid=2631&wire=1
Lead Plaintiff Deadline: September 9, 2019
Class Period: February 24, 2017 to May 22, 2019

Allegations against RLGY include that: (1) Realogy was engaged in anticompetitive behavior by requiring property sellers to pay the commissions of a buyer’s broker at an inflated rate; (2) Realogy’s anticompetitive actions would prompt the U.S. Department of Justice (“DOJ”) to open an antitrust investigation into the real estate industry’s practices regarding brokers’ commissions; and (3) as a result, Defendants’ statements about the Realogy’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

L Brands, Inc. (NYSE: LB)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/l-brands-inc-loss-submission-form?prid=2631&wire=1
Lead Plaintiff Deadline: September 23, 2019
Class Period: May 31, 2018 to November 19, 2018

Allegations against LB include that: (a) the Victoria’s Secret and PINK businesses were having a material adverse effect on the Company’s cash flow, liquidity and debt levels; (b) Defendants lacked a reasonable basis for their positive statements about the ability of the Company to sustain its dividend; (c) the MD&A disclosures in filings L Brands made with the SEC were materially false and misleading; (d) the risk factor disclosures in filings L Brands made with the SEC were materially false and misleading; (e) the representations about L Brands’ disclosure controls in filings the Company made with the SEC were materially false and misleading; (f) the certifications issued by Defendants Wexner and Burgdoerfer on L Brands disclosure controls were materially false and misleading; and (g) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about L Brands’ then-current business operations and future financial
prospects.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 553625

NEW YORK, NY / ACCESSWIRE / July 26, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Sunlands Technology Group (NYSE: STG)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/sunlands-technology-group-loss-submission-form?prid=2630&wire=1
Lead Plaintiff Deadline: August 26, 2019
Class Period: shareholders of Sunlands Technology Group who purchased shares pursuant and/or traceable to Sunlands’ March 2018 initial public stock offering.

Allegations against STG include that: (1) Sunlands’ student enrollment was declining; (2) Sunlands’ gross billings were declining; (3) Sunlands’ marketing tactics were not as robust as described in the Registration Statement; and (4) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Pivotal Software, Inc. (NYSE: PVTL)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/pivotal-software-inc-loss-submission-form?prid=2630&wire=1
Lead Plaintiff Deadline: August 19, 2019
Class Period: investors who purchased common stock pursuant or traceable to the April 2018 initial public offering and/or Pivotal securities between April 24, 2018 and June 4, 2019.

Allegations against PVTL include that: (i) Pivotal was facing major problems with its sales execution and a complex technology landscape; (ii) the foregoing headwinds resulted in deferred sales, lengthening sales cycles, and diminished growth as its customers and the industry’s sentiment shifted away from Pivotal’s principal products because the Company’s products were outdated, inadequate, and incompatible with the industry-standard platform; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Reckitt Benckiser Group plc (OTCMKTS: RBGLY)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/reckitt-benckiser-group-plc-loss-submission-form?prid=2630&wire=1
Lead Plaintiff Deadline: September 13, 2019
Class Period: On behalf of all purchasers of Reckitt American Depositary Shares (“ADSs”) from July 28, 2014 through April 9, 2019

Allegations against RBGLY include that: (a) defendants had engaged in a scheme to artificially inflate the sales of Suboxone Film by more than $3 billion by falsely touting the drug’s purportedly superior efficacy and safety as compared to tablets; (b) contrary to defendants’ public statements, the FDA and internal Company documents had concluded that Suboxone Film posed a potentially greater risk of abuse and child endangerment than other available treatments; (c) defendants had fabricated a safety scare involving Suboxone Tablets in order to unlawfully delay and prevent generic competition; (d) defendants had engaged in a massive marketing campaign that had misrepresented the purported benefits of Suboxone Film as compared to Suboxone Tablets to doctors, healthcare providers, government regulators and investors; (e) defendants had encouraged Suboxone sales through medical providers that they knew were overprescribing the drug, facilitating the drug’s abuse and/or prescribing it in a careless and clinically unwarranted manner, often to hundreds of individuals at a time; (f) as a result of (a)-(e) above, Reckitt’s revenues, net income an d earnings were artificially inflated and the product of illicit business practices; and (g) as a result of (a)-(f) above, Reckitt and Reckitt Pharma were exposed to extraordinary undisclosed legal and reputational risks that could result in billions of dollars in fines, lost business and legal judgments or other monetary penalties.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 553624

NEW YORK, NY / ACCESSWIRE / July 26, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Bloom Energy Corporation (NYSE: BE)

Investors Affected : on behalf of all persons who purchased or otherwise acquired Bloom Energy common stock pursuant or traceable to Bloom Energy’s July 2018 IPO.

A class action has commenced on behalf of certain shareholders in Bloom Energy Corporation. The complaint alleges that Bloom Energy’s Registration Statement was materially misleading as it failed to disclose known events and trends that were severely affecting the Company’s business and that made investment in Bloom Energy significantly riskier than presented in the Registration Statement. In particular, the Registration Statement failed to disclose that the Company was experiencing material construction delays. These construction delays would cause system deployments (or “acceptances” as Defendants referred to them) to fall significantly below even the low end of the Company’s previously announced guidance.
While the Registration Statement purported to warn of risks that “may arise,” which could materially affect the Company, in actuality these material negative events were already occurring. As a result, the representations and purported risk disclosures were false and misleading because, by the time of the IPO, construction delays had already impacted or would soon impact Bloom Energy’s ability to deliver acceptances in line with its guidance.

Shareholders may find more information at https://securitiesclasslaw.com/securities/bloom-energy-corporation-loss-submission-form/?id=2629&from=1

Ra Medical Systems, Inc. (NYSE: RMED)

Investors Affected : stockholders that purchased Ra Medical securities pursuant and/or traceable to the Company’s September 2018 initial public offering.

A class action has commenced on behalf of certain shareholders in Ra Medical Systems, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s evaluation of sales personnel candidates was inadequate; (2) the Company’s training program for sales personnel was inadequate; (3) as a result, the Company could not reasonably assure that its newly hired sales personnel were adequately experienced; (4) as a result, the Company would suffer a shortage of qualified sales personnel; (5) the Company’s manufacturing process could not reasonably support increased catheter production; (6) as a result, the Company would suffer production delays; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/ra-medical-systems-inc-loss-submission-form/?id=2629&from=1

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA)

Investors Affected : on behalf of all persons or entities who purchased or otherwise acquired Teva American Depositary Shares (“ADS”) between August 4, 2017 and May 10, 2019

A class action has commenced on behalf of certain shareholders in Teva Pharmaceutical Industries Ltd. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) contrary to its public denials, Teva had in fact engaged in a vast, industry-wide price-fixing scheme and other collusive misconduct since at least 2012; (ii) Teva was not only a participant, but the company at the heart of the anticompetitive scheme; and (iii) several Teva employees had such deep involvement in the scheme that they would ultimately be named personally as defendants in a sweeping civil enforcement action filed by the AGs of virtually every state in the nation.

Shareholders may find more information at https://securitiesclasslaw.com/securities/teva-pharmaceutical-industries-ltd-loss-submission-form/?id=2629&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 553623

TORONTO, ON / ACCESSWIRE / July 26, 2019 / StageZero Life Sciences Ltd (TSX: SZLS) (“StageZero” or the “Company”) today announced the second closing for $1,043,049 to complete the $3.708 million private placement financing round as approved by shareholders at the Company’s Annual and Special Meeting. The private placement is fully subscribed.

A total of 75 investors participated for total gross proceeds of $3,708,467. The private placement is structured as units at $0.115 and each unit includes one common share and one half warrant, whereby each full warrant can be exercised for a period of 36 months at a price of $0.185.

“We are already deploying the funds gained through the financing to expand our commercialization and the final validation of Aristotle,” said James R Howard-Tripp, Chief Executive Officer of StageZero Life Sciences Ltd. “The funding will also provide the company with the necessary finances to support the distribution agreements with additional telehealth partners and our new sales partner Coastal Medical, as well as our collaboration with a large healthcare system”.

About StageZero Life Sciences, Ltd.

StageZero Life Sciences is dedicated to the early detection (Stage 0) of cancer and multiple disease states through whole blood. Our next generation test, Aristotle®, is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on our proven and proprietary Sentinel Principle Technology Platform which was validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer. Further validation of Aristotle is currently underway. In addition to building a pipeline of products for early cancer detection, the Company operates a CAP accredited and CLIA certified reference laboratory based in Richmond, Virginia that offers the ColonSentry® test as well as licensed biomarker tests for lung, breast and prostate cancers. To learn more visit www.stagezerolifesciences.com

Forward-Looking Statements

This press release contains forward-looking statements identified by words such as “expects”, “will” and similar expressions, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company’s actual events to differ materially from those projected herein. Investors should consult the Company’s ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.

Company Contact:

James R. Howard-Tripp
Chairman & CEO
jht@stagezerols.com
Tel: 1-855-420-7140 Ext. 1

Jerome Cliche
Financial Communication Advisor
jcliche@stagezerols.com
Tel. (514) 815-8799

SOURCE: StageZero Life Sciences Ltd

ReleaseID: 553622

LOS ANGELES, CA / ACCESSWIRE / July 26, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Metro Bank PLC (“Metro Bank” or “the Company”) (OTC PINK: MBNKF) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s shares between March 6, 2018 and May 1, 2019, inclusive (the ”Class Period”), are encouraged to contact the firm before July 29, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Metro Bank failed to properly classify the risk of its loan portfolio. Subsequently, the Company failed to maintain appropriate levels of capital. These actions led to investigations by the Prudential Regulation Authority and Financial Conduct Authority. It also led to the Company losing deposits from major commercial clients. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Metro Bank, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 553614